Market Overview:
The global hemostat powder market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising awareness about hemostats, and technological advancements in the field of hemostats. Based on type, the global hemostat powder market is segmented into gelatin, fibrin, cellulose, and others. Gelatin dominates this market owing to its high biocompatibility and easy availability. Fibrin-based products are expected to grow at a higher rate during the forecast period as they offer several advantages over other types of products such as better clotting ability and faster healing time. Based on application, surgical wound care dominates this market followed by general wound care. The growth in surgical wound care can be attributed to increasing number of surgeries performed each year coupled with rising awareness about benefits offered by using hemostats in surgery procedures.
Product Definition:
Hemostat Powder is a medical powder that is used to stop bleeding. It clots the blood and helps to form a scab over the wound. Hemostat Powder can be used on any type of wound, including cuts, scrapes, and burns.
Gelatin:
Gelatin is a protein derived from collagen. It has the ability to form cross-linked polysaccharide matrices that are used in hemostats for measuring blood volume and pressure. The most common sources of gelatin are meat, fish skin, and bone marrow. Gelatin is also produced commercially from bacterial fermentation which makes it an attractive product for use in pharmaceuticals as well as food additives.
Fibrin:
Fibrin is a blood clotting agent and hemostat. It is produced by the liver in response to injury or trauma to the blood vessels. Fibrinogen is an initial step in fibrin formation and it helps in maintaining normal blood flow through the vascular system.
Application Insights:
Based on the application, the global hemostat powder market is segmented into surgical wound care, general wound care and others. The surgical wound care segment dominated the overall market in terms of revenue share in 2017. This can be attributed to increasing number of surgeries and rising cases of chronic diseases such as diabetes and cancer across various regions. As a result, there is an increased demand for hemostat for surgical wounds management which drives growth.
The other applications include oral surgery & periodontology, transdermal drug delivery systems (TTD), ophthalmic surgery & dermatology among others which are expected to exhibit significant growth over the forecast period owing to increasing product usage in these segments by healthcare professionals due to its properties such as ease of use with minimal risk of infection or allergic reaction among others leading to increased adoption rate globally.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period due to increasing cases of chronic wounds, burns, and surgical procedures. In addition, rising prevalence of diabetes is also anticipated to propel demand for hemostats powder during the forecast period.
Asia Pacific is expected to witness lucrative growth over the coming years owing to rapidly growing medical tourism industry in emerging economies such as India and China. Rising healthcare expenditure by governments along with an increase in disposable income levels are some factors that are likely contribute toward regional growth during the forecast period.
Growth Factors:
- Increasing incidence of bleeding disorders and surgeries is expected to drive the demand for hemostat powder over the forecast period.
- Growing awareness about the benefits of using hemostat powders is projected to boost market growth.
- Technological advancements in hemostatic products are anticipated to create new opportunities for market players.
- Rising number of product approvals by regulatory authorities is likely to propel demand for hemostat powders during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemostat Powder Market Research Report
By Type
Gelatin, Fibrin, Cellulose, Others
By Application
Surgical Wound Care, General Wound Care
By Companies
Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring, Gelita Medical, Ferrosan Medical Devices, Baxter, Celox, Equimedical, Medira, Biocer, Hemostasis, MBP
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Hemostat Powder Market Report Segments:
The global Hemostat Powder market is segmented on the basis of:
Types
Gelatin, Fibrin, Cellulose, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Surgical Wound Care, General Wound Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- C. R. Bard
- Pfizer
- CSL Behring
- Gelita Medical
- Ferrosan Medical Devices
- Baxter
- Celox
- Equimedical
- Medira
- Biocer
- Hemostasis
- MBP
Highlights of The Hemostat Powder Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gelatin
- Fibrin
- Cellulose
- Others
- By Application:
- Surgical Wound Care
- General Wound Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemostat Powder Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemostat powder is a medication used to temporarily stop the bleeding from cuts, wounds, and other injuries. Hemostat powder can be applied directly to the wound or mixed with water and applied as a spray.
Some of the key players operating in the hemostat powder market are Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring, Gelita Medical, Ferrosan Medical Devices, Baxter, Celox, Equimedical, Medira, Biocer, Hemostasis, MBP.
The hemostat powder market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemostat Powder Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemostat Powder Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemostat Powder Market - Supply Chain
4.5. Global Hemostat Powder Market Forecast
4.5.1. Hemostat Powder Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemostat Powder Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemostat Powder Market Absolute $ Opportunity
5. Global Hemostat Powder Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemostat Powder Market Size and Volume Forecast by Type
5.3.1. Gelatin
5.3.2. Fibrin
5.3.3. Cellulose
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemostat Powder Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemostat Powder Market Size and Volume Forecast by Application
6.3.1. Surgical Wound Care
6.3.2. General Wound Care
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemostat Powder Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemostat Powder Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemostat Powder Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemostat Powder Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemostat Powder Demand Share Forecast, 2019-2026
9. North America Hemostat Powder Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemostat Powder Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemostat Powder Market Size and Volume Forecast by Application
9.4.1. Surgical Wound Care
9.4.2. General Wound Care
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemostat Powder Market Size and Volume Forecast by Type
9.7.1. Gelatin
9.7.2. Fibrin
9.7.3. Cellulose
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemostat Powder Demand Share Forecast, 2019-2026
10. Latin America Hemostat Powder Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemostat Powder Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemostat Powder Market Size and Volume Forecast by Application
10.4.1. Surgical Wound Care
10.4.2. General Wound Care
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemostat Powder Market Size and Volume Forecast by Type
10.7.1. Gelatin
10.7.2. Fibrin
10.7.3. Cellulose
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemostat Powder Demand Share Forecast, 2019-2026
11. Europe Hemostat Powder Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemostat Powder Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemostat Powder Market Size and Volume Forecast by Application
11.4.1. Surgical Wound Care
11.4.2. General Wound Care
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemostat Powder Market Size and Volume Forecast by Type
11.7.1. Gelatin
11.7.2. Fibrin
11.7.3. Cellulose
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemostat Powder Demand Share, 2019-2026
12. Asia Pacific Hemostat Powder Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemostat Powder Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemostat Powder Market Size and Volume Forecast by Application
12.4.1. Surgical Wound Care
12.4.2. General Wound Care
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemostat Powder Market Size and Volume Forecast by Type
12.7.1. Gelatin
12.7.2. Fibrin
12.7.3. Cellulose
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemostat Powder Demand Share, 2019-2026
13. Middle East & Africa Hemostat Powder Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemostat Powder Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemostat Powder Market Size and Volume Forecast by Application
13.4.1. Surgical Wound Care
13.4.2. General Wound Care
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemostat Powder Market Size and Volume Forecast by Type
13.7.1. Gelatin
13.7.2. Fibrin
13.7.3. Cellulose
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemostat Powder Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemostat Powder Market: Market Share Analysis
14.2. Hemostat Powder Distributors and Customers
14.3. Hemostat Powder Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Johnson & Johnson
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. C. R. Bard
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CSL Behring
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Gelita Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ferrosan Medical Devices
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Baxter
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Celox
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Equimedical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Medira
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Biocer
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Hemostasis
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. MBP
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
